Single Injection Technique Prolotherapy for Hypermobility Disorders of TMJ Using 25 % Dextrose: A Clinical Study

Dextrose prolotherapy for recalcitrant coccygodynia.

PURPOSE To present the results of dextrose prolotherapy undertaken for chronic non-responding coccygodynia in 37 patients. METHODS 14 men and 23 women (mean age, 36 years) with chronic coccygodynia not responding to conservative treatment for more than 6 months were included. 27 of them had received local steroid injections. A visual analogue score (VAS) was recorded for all patients before a...

The Efficacy of Dextrose Prolotherapy for Temporomandibular Joint Hypermobility (2011) Refai H, Altahhan O, Elsharkawy R.[Epub ahead of print] The Efficacy of Dextrose Prolotherapy for Temporomandibular Joint Hypermobility: A Preliminary Prospective,

Treating Osteoarthritic Joints Using Dextrose Prolotherapy and Direct Bone Marrow Aspirate Injection Therapy

Osteoarthritis is a chronic, progressive disease of the articular joints, and to date, has no cure or effective longterm treatment. Objective: To determine if bone marrow prolotherapy (BMP), a combined treatment protocol employing separate injections of hypertonic dextrose prolotherapy and bone marrow aspirate, would be effective as a means of reducing joint pain and improving function in osteo...

Periarticular dextrose prolotherapy instead of intra-articular injection for pain and functional improvement in knee osteoarthritis

BACKGROUND Osteoarthritis (OA) is a degenerative disease that can lead to painful and dysfunctional joints. Prolotherapy involves using injections to produce functional restoration of the soft tissues of the joint. Intra-articular injections are controversial because of the introduction of needles into the articular capsule. OBJECTIVES To compare the effect of periarticular versus intra-artic...

P02.23. The efficacy of prolotherapy using dextrose-morrhuate for lateral epicondylosis: a pilot randomized controlled trial

Methods The study design was a 2-arm non-blinded randomized controlled trial. Group 1 received dextrose prolotherapy and Group 2 was a waitlist control. Nineteen adults seen with at least 3 months of symptomatic CLE in 22 elbows refractory to prior care received ultrasound-guided injections of 20% dextrose-morrhuate sodium (Group 1) solution at baseline, 4, and 8 weeks. Waitlist subjects (Group...